Beta Bionics, Inc. BBNX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.54% | -- | -- | -- | -60.33% |
| Total Depreciation and Amortization | 55.06% | -- | -- | -- | 42.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.95% | -- | -- | -- | 21.31% |
| Change in Net Operating Assets | 30.51% | -- | -- | -- | -54.33% |
| Cash from Operations | 2.87% | -- | -- | -- | -87.00% |
| Capital Expenditure | -21.92% | -- | -- | -- | -274.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 135.30% | -- | -- | -- | -217.94% |
| Cash from Investing | 131.44% | -- | -- | -- | -219.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.09% | -- | -- | -- | 782,288.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -3,284.87% |
| Cash from Financing | -97.70% | -- | -- | -- | 290,183.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.08% | -- | -- | -- | 124.64% |